GoodRx Holdings, Inc.
GDRX
$3.44
-$0.01-0.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 200.41M | 194.01M | 194.79M | 196.03M | 203.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 200.41M | 194.01M | 194.79M | 196.03M | 203.07M |
| Cost of Revenue | 21.00M | 20.16M | 17.46M | 13.42M | 13.35M |
| Gross Profit | 179.41M | 173.85M | 177.32M | 182.61M | 189.72M |
| SG&A Expenses | 106.80M | 107.87M | 91.96M | 115.55M | 113.25M |
| Depreciation & Amortization | 22.27M | 21.79M | 23.15M | 21.43M | 19.73M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 176.78M | 180.00M | 157.81M | 181.41M | 176.26M |
| Operating Income | 23.63M | 14.01M | 36.98M | 14.62M | 26.81M |
| Income Before Tax | 15.47M | 5.64M | 14.19M | 6.10M | 19.58M |
| Income Tax Expenses | 6.93M | 4.47M | 8.77M | 4.98M | 6.73M |
| Earnings from Continuing Operations | 8.54M | 1.17M | 5.43M | 1.12M | 12.84M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.54M | 1.17M | 5.43M | 1.12M | 12.84M |
| EBIT | 23.63M | 14.01M | 36.98M | 14.62M | 26.81M |
| EBITDA | 45.90M | 35.80M | 60.12M | 36.05M | 46.54M |
| EPS Basic | 0.03 | 0.00 | 0.02 | 0.00 | 0.04 |
| Normalized Basic EPS | 0.03 | 0.01 | 0.05 | 0.01 | 0.03 |
| EPS Diluted | 0.02 | 0.00 | 0.02 | 0.00 | 0.04 |
| Normalized Diluted EPS | 0.03 | 0.01 | 0.05 | 0.01 | 0.03 |
| Average Basic Shares Outstanding | 339.28M | 340.53M | 340.21M | 346.78M | 356.62M |
| Average Diluted Shares Outstanding | 348.06M | 341.42M | 340.76M | 347.81M | 357.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |